title: Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin.
authors.affiliation: Department of Gynaecology, Glasgow Royal Infirmary, Scotland, UK.
authors.forename: K
authors.initials: K
authors.lastname: Phillips
authors.forename: C
authors.initials: C
authors.lastname: Berry
authors.forename: A M
authors.initials: AM
authors.lastname: Mathers
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects*; D000032:Abortion, Therapeutic / Q000009:adverse effects*; D000328:Adult; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D016595:Misoprostol / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D014597:Uterine Rupture / Q000139:chemically induced*
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone